Literature DB >> 9823634

[5-years lithotripsy of plantar of plantar heel spur: experiences and results--a follow-up study after 36.9 months].

R Sistermann1, B D Katthagen.   

Abstract

INTRODUCTION: Effectivity and application as well as possible complications and side effects of extracorporeal shock wave lithotripsy of plantar heel spurs should be evaluated.
METHOD: We applied extracorporeal shock wave lithotripsy (ECSL) to treat plantar fasciitis in 54 patients (period from: 3/1/1993 to 3/1/1996). 20 persons were treated with Lithostar plus (group 1) and ultrasound focussing and 34 patients (group 2) were treated by a Lithostar and X-ray focussing.
RESULTS: After 6 weeks 14 (70%) of group 1 and 27 (79.4%) of group 2 were free of pain. After 36.9 months 8 (40%) of group 1 and 23 (67.6%) of group 2 were still painfree. We could not recognize any severe complications after 36.9 months.
CONCLUSION: ECSL is an effective and noninvasive method of treatment. It is not the method of choice for the first treatment of plantar fasciitis but is an alternative option for operation.

Entities:  

Mesh:

Year:  1998        PMID: 9823634     DOI: 10.1055/s-2008-1053675

Source DB:  PubMed          Journal:  Z Orthop Ihre Grenzgeb        ISSN: 0044-3220


  3 in total

1.  Randomized multicenter trial on the effect of radiotherapy for plantar Fasciitis (painful heel spur) using very low doses--a study protocol.

Authors:  Marcus Niewald; M Heinrich Seegenschmiedt; Oliver Micke; Stefan Gräber
Journal:  Radiat Oncol       Date:  2008-09-18       Impact factor: 3.481

2.  Randomized multicenter follow-up trial on the effect of radiotherapy for plantar fasciitis (painful heels spur) depending on dose and fractionation - a study protocol.

Authors:  Henrik Holtmann; Marcus Niewald; Benjamin Prokein; Stefan Graeber; Christian Ruebe
Journal:  Radiat Oncol       Date:  2015-01-20       Impact factor: 3.481

3.  Low-dose radiation treatment for painful plantar enthesophyte: a highly effective therapy with little side effects.

Authors:  Freddy Djiepmo; Bálint Tamaskovics; Edwin Bölke; Matthias Peiper; Jan Haussmann; Judith Neuwahl; Danny Jazmati; Kitti Maas; Livia Schmidt; Roman Gelzhäuser; Christoph Schleich; Stefanie Corradini; Klaus Orth; Martijn van Griensven; Amir Rezazadeh; Kimia Karimi; Wilfried Budach; Christiane Matuschek
Journal:  Eur J Med Res       Date:  2022-02-23       Impact factor: 2.175

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.